AJR ARRS: Your Link to CME
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Editor's Commentary
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Broome, D. R.
Right arrow Articles by Kirk, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Broome, D. R.
Right arrow Articles by Kirk, G. A.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
DOI:10.2214/AJR.06.1094
AJR 2007; 188:586-592
© American Roentgen Ray Society

Original Research

Gadodiamide-Associated Nephrogenic Systemic Fibrosis: Why Radiologists Should Be Concerned

Dale R. Broome1, Mark S. Girguis1, Pedro W. Baron2, Alfred C. Cottrell3, Ingrid Kjellin1 and Gerald A. Kirk1

1 Department of Radiology, Loma Linda University Medical Center, 11234 Anderson St., MC Room 2605, Loma Linda, CA 92354.
2 Department of Surgery, Transplant Division, Loma Linda University Medical Center, Loma Linda, CA.
3 Department of Medicine, Nephrology Division, Loma Linda University Medical Center, Loma Linda, CA.

OBJECTIVE. Nephrogenic systemic fibrosis (NSF) is a rare multisystemic fibrosing disorder that principally affects the skin but may affect other organs of patients with renal insufficiency. The purpose of our study was to identify any common risk factors and determine whether IV gadodiamide is associated with the development of NSF.

MATERIALS AND METHODS. A retrospective chart review was performed for all 12 patients diagnosed with NSF at our institution between 2000 and 2006 to identify the clinical manifestations, timing, and dose of gadodiamide administration; dialysis records; concurrent medications; comorbid conditions and surgeries; laboratory findings; imaging findings; and clinical outcome. A review of the dialysis and MR records between 2000 and 2006 showed 559 MRI examinations on 168 dialysis patients (including 301 contrast-enhanced examinations).

RESULTS. NSF was diagnosed by clinical findings and tissue diagnosis. All 12 patients had renal insufficiency—eight with dialysis-dependent chronic renal insufficiency and four with acute hepatorenal syndrome. All 12 patients developed skin fibrosis within 2-11 weeks after gadodiamide administration. The odds ratio for development of NSF after gadodiamide exposure was 22.3. No other common event or exposure could be found. Four patients had abnormal scintigraphic bone scans with skin and muscle uptake and lower-extremity MRI finding of edema in the muscles, intermuscular fascia, and skin. Despite the fact that 10 patients were dialyzed within 2 days of gadodiamide administration, this did not prevent the development of NSF.

CONCLUSION. Development of NSF was strongly associated with gadodiamide administration in the setting of either acute hepatorenal syndrome or dialysis-dependent chronic renal insufficiency.

Keywords: dialysis • MR contrast agents • MR imaging • nephrogenic systemic fibrosis • nuclear medicine • renal disease


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 RadiologyHome page
T. A. Hope, W. A. High, P. E. LeBoit, B. Chaopathomkul, V. S. Rogut, R. J. Herfkens, and R. C. Brasch
Nephrogenic Systemic Fibrosis in Rats Treated with Erythropoietin and Intravenous Iron
Radiology, November 1, 2009; 253(2): 390 - 398.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
E. Altun, D. R. Martin, R. Wertman, A. Lugo-Somolinos, E. R. Fuller 3rd, and R. C. Semelka
Nephrogenic Systemic Fibrosis: Change in Incidence Following a Switch in Gadolinium Agents and Adoption of a Gadolinium Policy--Report from Two U.S. Universities
Radiology, October 7, 2009; (2009) radiol.2533090649v2.
[Abstract] [Full Text]

Home page
 Arch DermatolHome page
C. U. Lee, C. M. Wood, G. K. Hesley, N. Leung, M. D. Bridges, J. T. Lund, P. U. Lee, and M. R. Pittelkow
Large Sample of Nephrogenic Systemic Fibrosis Cases From a Single Institution
Arch Dermatol, October 1, 2009; 145(10): 1095 - 1102.
[Abstract] [Full Text] [PDF]

Home page
 Arch DermatolHome page
W. A. High
Estimates of Risk, Empirical Treatment Observations, and Unexpected Laboratory Findings Reveal the Complexity of Nephrogenic Systemic Fibrosis
Arch Dermatol, October 1, 2009; 145(10): 1178 - 1182.
[Full Text] [PDF]

Home page
 RadioGraphicsHome page
M. R. Prince, H. L. Zhang, J. C. Prowda, M. E. Grossman, and D. N. Silvers
Nephrogenic Systemic Fibrosis and Its Impact on Abdominal Imaging
RadioGraphics, October 1, 2009; 29(6): 1565 - 1574.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
B. Driehuys, H. E. Moller, Z. I. Cleveland, J. Pollaro, and L. W. Hedlund
Pulmonary Perfusion and Xenon Gas Exchange in Rats: MR Imaging with Intravenous Injection of Hyperpolarized 129Xe
Radiology, August 1, 2009; 252(2): 386 - 393.
[Abstract] [Full Text] [PDF]

Home page
 radtechHome page
A. THENGAMPALLIL and S. S THENGAMPALLIL
Pharmacology in Radiology
Radiol. Technol., July 1, 2009; 80(6): 547 - 563.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
I. Boehm
Which laboratory parameters are characteristic for nephrogenic systemic fibrosis?
Nephrol. Dial. Transplant., July 1, 2009; 24(7): 2293 - 2293.
[Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
M. F. Morris, Y. Zhang, H. Zhang, J. C. Prowda, D. N. Silvers, R. A. Fawwaz, and M. R. Prince
Features of Nephrogenic Systemic Fibrosis on Radiology Examinations
Am. J. Roentgenol., July 1, 2009; 193(1): 61 - 69.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
R. Agarwal, S. M. Brunelli, and C. A. Umscheid
Reply
Nephrol. Dial. Transplant., July 1, 2009; 24(7): 2293 - 2294.
[Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
D. Kaya, A. Dincer, M.E. Yildiz, M.O. Cizmeli, and C. Erzen
Acute Ischemic Infarction Defined by a Region of Multiple Hypointense Vessels on Gradient-Echo T2* MR Imaging at 3T
AJNR Am. J. Neuroradiol., June 1, 2009; 30(6): 1227 - 1232.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
M. D. Bridges, B. S. St. Amant, R. B. McNeil, J. G. Cernigliaro, J. P. Dwyer, and P. M. Fitzpatrick
High-Dose Gadodiamide for Catheter Angiography and CT in Patients With Varying Degrees of Renal Insufficiency: Prevalence of Subsequent Nephrogenic Systemic Fibrosis and Decline in Renal Function
Am. J. Roentgenol., June 1, 2009; 192(6): 1538 - 1543.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
K. Nael, M. Krishnam, S. G. Ruehm, H. J. Michaely, G. Laub, and J. P. Finn
Time-Resolved MR Angiography in the Evaluation of Central Thoracic Venous Occlusive Disease
Am. J. Roentgenol., June 1, 2009; 192(6): 1731 - 1738.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
A. Kribben, O. Witzke, U. Hillen, J. Barkhausen, A. E. Daul, and R. Erbel
Nephrogenic systemic fibrosis: pathogenesis, diagnosis, and therapy.
J. Am. Coll. Cardiol., May 5, 2009; 53(18): 1621 - 1628.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Melmed, A. Colao, A. Barkan, M. Molitch, A. B. Grossman, D. Kleinberg, D. Clemmons, P. Chanson, E. Laws, J. Schlechte, et al.
Guidelines for Acromegaly Management: An Update
J. Clin. Endocrinol. Metab., May 1, 2009; 94(5): 1509 - 1517.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
R. Agarwal, S. M. Brunelli, K. Williams, M. D. Mitchell, H. I. Feldman, and C. A. Umscheid
Gadolinium-based contrast agents and nephrogenic systemic fibrosis: a systematic review and meta-analysis
Nephrol. Dial. Transplant., March 1, 2009; 24(3): 856 - 863.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Radiol.Home page
H S SU, R M NAZARIAN, and J A SCOTT
Appearance of nephrogenic fibrosing dermopathy on a bone scan
Br. J. Radiol., February 1, 2009; 82(974): e35 - e36.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
J. Perez-Rodriguez, S. Lai, B. D. Ehst, D. M. Fine, and D. A. Bluemke
Nephrogenic Systemic Fibrosis: Incidence, Associations, and Effect of Risk Factor Assessment--Report of 33 Cases
Radiology, February 1, 2009; 250(2): 371 - 377.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
M. A. Perazella
Current Status of Gadolinium Toxicity in Patients with Kidney Disease
Clin. J. Am. Soc. Nephrol., February 1, 2009; 4(2): 461 - 469.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
K. Juluru, J. Vogel-Claussen, K. J. Macura, I. R. Kamel, A. Steever, and D. A. Bluemke
Quality Initiatives MR Imaging in Patients at Risk for Developing Nephrogenic Systemic Fibrosis: Protocols, Practices, and Imaging Techniques to Maximize Patient Safety1
RadioGraphics, January 1, 2009; 29(1): 9 - 22.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
K. Juluru, J. Vogel-Claussen, K. J. Macura, I. R. Kamel, A. Steever, and D. A. Bluemke
MR Imaging in Patients at Risk for Developing Nephrogenic Systemic Fibrosis: Protocols, Practices, and Imaging Techniques to Maximize Patient Safety
RadioGraphics, November 19, 2008; (2008) 291085072.
[Abstract] [Full Text]

Home page
 JAMAHome page
K. Rosenfield and M. R. Jaff
An 82-Year-Old Woman With Worsening Hypertension: Review of Renal Artery Stenosis
JAMA, November 5, 2008; 300(17): 2036 - 2044.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll Cardiol ImgHome page
A. Chiribiri, S. Kelle, U. Kohler, L. F. Tops, B. Schnackenburg, R. Bonamini, J. J. Bax, E. Fleck, and E. Nagel
Magnetic resonance cardiac vein imaging: relation to mitral valve annulus and left circumflex coronary artery.
J. Am. Coll. Cardiol. Img., November 1, 2008; 1(6): 729 - 738.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
S. Zelasko, M. Hollingshead, M. Castillo, and T.W. Bouldin
CT and MR Imaging of Progressive Dural Involvement by Nephrogenic Systemic Fibrosis
AJNR Am. J. Neuroradiol., November 1, 2008; 29(10): 1880 - 1882.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
J. C. Weinreb
Which Study When? Is Gadolinium-enhanced MR Imaging Safer than Iodine-enhanced CT?
Radiology, October 1, 2008; 249(1): 3 - 8.
[Full Text] [PDF]

Home page
 NDT PlusHome page
G. Bayliss, W. Jacobs, and M. Williams
Renal failure and abdominal pain as the presenting symptoms of a rare tumor of the aorta masquerading as a calcified plaque
NDT Plus, October 1, 2008; 1(5): 316 - 318.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
F. G. Shellock and A. Spinazzi
MRI Safety Update 2008: Part 1, MRI Contrast Agents and Nephrogenic Systemic Fibrosis
Am. J. Roentgenol., October 1, 2008; 191(4): 1129 - 1139.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
P. M. Colletti
Nephrogenic Systemic Fibrosis and Gadolinium: A Perfect Storm
Am. J. Roentgenol., October 1, 2008; 191(4): 1150 - 1153.
[Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
C. S. Ng, C. G. Wood, P. M. Silverman, N. M. Tannir, P. Tamboli, and C. M. Sandler
Renal Cell Carcinoma: Diagnosis, Staging, and Surveillance
Am. J. Roentgenol., October 1, 2008; 191(4): 1220 - 1232.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
M. R. Prince, H. Zhang, M. Morris, J. L. MacGregor, M. E. Grossman, J. Silberzweig, R. L. DeLapaz, H. J. Lee, C. M. Magro, and A. M. Valeri
Incidence of Nephrogenic Systemic Fibrosis at Two Large Medical Centers
Radiology, September 1, 2008; 248(3): 807 - 816.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
R. Habibi, M. S. Krishnam, D. G. Lohan, F. Barkhordarian, M. Jalili, R. S. Saleh, S. G. Ruehm, and J. P. Finn
High-Spatial-Resolution Lower Extremity MR Angiography at 3.0 T: Contrast Agent Dose Comparison Study
Radiology, August 1, 2008; 248(2): 680 - 692.
[Abstract] [Full Text] [PDF]

Home page
 NDT PlusHome page
H. Pieringer, S. Schumacher, B. Schmekal, T. Gitter, and G. Biesenbach
Gadolinium-based contrast agents, erythropoietin and nephrogenic systemic fibrosis in patients with end-stage renal failure
NDT Plus, June 1, 2008; 1(3): 193 - 194.
[Full Text] [PDF]

Home page
 RadiologyHome page
N. M. Rofsky, A. D. Sherry, and R. E. Lenkinski
Nephrogenic Systemic Fibrosis: A Chemical Perspective
Radiology, June 1, 2008; 247(3): 608 - 612.
[Full Text] [PDF]

Home page
 RadiologyHome page
Y. Tsushima, A. Takahashi-Taketomi, and K. Endo
Nephrogenic Systemic Fibrosis in Japan: Advisability of Keeping the Administered Dose as Low as Possible
Radiology, June 1, 2008; 247(3): 915 - 916.
[Full Text] [PDF]

Home page
 CJASNHome page
R. F. Reilly
Risk for Nephrogenic Systemic Fibrosis with Gadoteridol (ProHance) in Patients Who Are on Long-Term Hemodialysis
Clin. J. Am. Soc. Nephrol., May 1, 2008; 3(3): 747 - 751.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
C. Y. Kim, R. A. Mirza, J. A. Bryant, E. D. Whiting, D. M. Delong, C. E. Spritzer, and E. M. Merkle
Central Veins of the Chest: Evaluation with Time-resolved MR Angiography
Radiology, May 1, 2008; 247(2): 558 - 566.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
C. D. Wiginton, B. Kelly, A. Oto, M. Jesse, P. Aristimuno, R. Ernst, and G. Chaljub
Gadolinium-Based Contrast Exposure, Nephrogenic Systemic Fibrosis, and Gadolinium Detection in Tissue
Am. J. Roentgenol., April 1, 2008; 190(4): 1060 - 1068.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
L. P. Golding and J. M. Provenzale
Nephrogenic Systemic Fibrosis: Possible Association with a Predisposing Infection
Am. J. Roentgenol., April 1, 2008; 190(4): 1069 - 1075.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
G. Soulez, M. Pasowicz, G. Benea, L. Grazioli, J. P. Niedmann, M. Konopka, P. C. Douek, G. Morana, F. K. W. Schaefer, A. Vanzulli, et al.
Renal Artery Stenosis Evaluation: Diagnostic Performance of Gadobenate Dimeglumine-enhanced MR Angiography--Comparison with DSA
Radiology, April 1, 2008; 247(1): 273 - 285.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
W. M. Shabana, R. H. Cohan, J. H. Ellis, H. K. Hussain, I. R. Francis, L. D. Su, S. K. Mukherji, and R. D. Swartz
Nephrogenic Systemic Fibrosis: A Report of 29 Cases
Am. J. Roentgenol., March 1, 2008; 190(3): 736 - 741.
[Abstract] [Full Text] [PDF]

Home page
 Cleveland Clinic Journal of MedicineHome page
N. ISSA, E. D. POGGIO, R. A. FATICA, R. PATEL, P. M. RUGGIERI, and R. J. HEYKA
Nephrogenic systemic fibrosis and its association with gadolinium exposure during MRI
Cleveland Clinic Journal of Medicine, February 1, 2008; 75(2): 95 - 111.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
M. Horger, G. Fierlbeck, J. Kuemmerle-Deschner, N. Tzaribachev, M. Wehrmann, C. D. Claussen, and J. Fritz
MRI Findings in Deep and Generalized Morphea (Localized Scleroderma)
Am. J. Roentgenol., January 1, 2008; 190(1): 32 - 39.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
C. U. Herborn, V. M. Runge, D. M. Watkins, J. M. Gendron, and L. G. Naul
MR Angiography of the Renal Arteries: Intraindividual Comparison of Double-Dose Contrast Enhancement at 1.5 T with Standard Dose at 3 T
Am. J. Roentgenol., January 1, 2008; 190(1): 173 - 177.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
J. R. Leyendecker, C. E. Barnes, and R. J. Zagoria
MR Urography: Techniques and Clinical Applications
RadioGraphics, January 1, 2008; 28(1): 23 - 46.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
J. R. Dillman, J. H. Ellis, R. H. Cohan, P. J. Strouse, and S. C. Jan
Frequency and Severity of Acute Allergic-Like Reactions to Gadolinium-Containing IV Contrast Media in Children and Adults
Am. J. Roentgenol., December 1, 2007; 189(6): 1533 - 1538.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
A. Kahana, M. J. Lucarelli, A. M. Grayev, J. J. Van Buren, C. N. Burkat, and L. R. Gentry
Noninvasive Dynamic Magnetic Resonance Angiography With Time-Resolved Imaging of Contrast KineticS (TRICKS) in the Evaluation of Orbital Vascular Lesions
Arch Ophthalmol, December 1, 2007; 125(12): 1635 - 1642.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
L A Ratnam, S R Nelson, and A M Belli
Investigating progressive unexplained renal impairment and hypertension
BMJ, November 24, 2007; 335(7629): 1094 - 1096.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
J. L. Nortier and V. del Marmol
Nephrogenic systemic fibrosis the need for a multidisciplinary approach
Nephrol. Dial. Transplant., November 1, 2007; 22(11): 3097 - 3101.
[Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
D. G. Lohan, F. Barkhordarian, R. Saleh, M. Krishnam, N. Salamon, S. G. Ruehm, and J. P. Finn
MR Angiography at 3 T for Assessment of the External Carotid Artery System
Am. J. Roentgenol., November 1, 2007; 189(5): 1088 - 1094.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
S. Thurnher, S. Miller, G. Schneider, C. Ballarati, G. Bongartz, C. U. Herborn, S. Schoenberg, M. A. Cova, G. Morana, K. Niazi, et al.
Diagnostic Performance of Gadobenate Dimeglumine Enhanced MR Angiography of the Iliofemoral and Calf Arteries: A Large-Scale Multicenter Trial
Am. J. Roentgenol., November 1, 2007; 189(5): 1223 - 1237.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
M. Shiehmorteza, R. F. Hanna, and M. S. Middleton
Can Gadopentetate Dimeglumine Be Safely Administered More Rapidly Than the FDA-Approved Injection Rate for Liver Imaging?
Am. J. Roentgenol., October 1, 2007; 189(4): W231 - W231.
[Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
D. R. Broome, A. C. Cottrell, and E. Kanal
Response to "Will Dialysis Prevent the Development of Nephrogenic Systemic Fibrosis After Gadolinium-Based Contrast Administration?"
Am. J. Roentgenol., October 1, 2007; 189(4): W234 - W235.
[Full Text] [PDF]

Home page
 RadiologyHome page
T. A. Collidge, P. C. Thomson, P. B. Mark, J. P. Traynor, A. G. Jardine, S. T. W. Morris, K. Simpson, and G. H. Roditi
Gadolinium-enhanced MR Imaging and Nephrogenic Systemic Fibrosis: Retrospective Study of a Renal Replacement Therapy Cohort
Radiology, October 1, 2007; 245(1): 168 - 175.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
S. Swaminathan and S. V. Shah
New Insights into Nephrogenic Systemic Fibrosis
J. Am. Soc. Nephrol., October 1, 2007; 18(10): 2636 - 2643.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
R. J. Gibbons, P. A. Araoz, and E. E. Williamson
The Year in Cardiac Imaging
J. Am. Coll. Cardiol., September 4, 2007; 50(10): 988 - 1003.
[Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
T. C. Lauenstein, K. Salman, R. Morreira, T. Heffron, J. R. Spivey, E. Martinez, P. Sharma, and D. R. Martin
Gadolinium-Enhanced MRI for Tumor Surveillance Before Liver Transplantation: Center-Based Experience
Am. J. Roentgenol., September 1, 2007; 189(3): 663 - 670.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
G. Saab, A. Abu-Alfa, E. A. Sadowski, and A. Djamali
Are Patients with Moderate Renal Failure at Risk for Developing Nephrogenic Systemic Fibrosis?
Radiology, September 1, 2007; 244(3): 930 - 932.
[Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
G. Saab and A. Abu-Alfa
Will Dialysis Prevent the Development of Nephrogenic Systemic Fibrosis After Gadolinium-Based Contrast Administration?
Am. J. Roentgenol., September 1, 2007; 189(3): W169 - W169.
[Full Text] [PDF]

Home page
 BMJHome page
P. C Thomson, T. A Collidge, P. B Mark, and J. P Traynor
Gadolinium contrast may be risky in kidney disease
BMJ, June 30, 2007; 334(7608): 1335 - 1336.
[Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
R. J. Stanley
Our Practice of Radiology: Reflections on its Growth and Stature
Am. J. Roentgenol., June 1, 2007; 188(6): 1439 - 1439.
[Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
E. Kanal, A. J. Barkovich, C. Bell, J. P. Borgstede, W. G. Bradley Jr., J. W. Froelich, T. Gilk, J. R. Gimbel, J. Gosbee, E. Kuhni-Kaminski, et al.
ACR Guidance Document for Safe MR Practices: 2007
Am. J. Roentgenol., June 1, 2007; 188(6): 1447 - 1474.
[Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
H. S. Thomsen and S. K. Morcos
Nephrogenic Systemic Fibrosis and Nonionic Linear Chelates
Am. J. Roentgenol., June 1, 2007; 188(6): W580 - W580.
[Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
D. R. Broome and M. S. Girguis
Reply
Am. J. Roentgenol., June 1, 2007; 188(6): W581 - W581.
[Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
Y.-Y. Ng, R.-C. Lee, S.-H. Shen, and G. Kirk
Gadolinium-Associated Nephrogenic Systemic Fibrosis: Double Dose, Not Single Dose
Am. J. Roentgenol., June 1, 2007; 188(6): W582 - W582.
[Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
D. R. Broome and M. S. Girguis
Reply
Am. J. Roentgenol., June 1, 2007; 188(6): W583 - W583.
[Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
S. J. Karlik
Gadodiamide-Associated Nephrogenic Systemic Fibrosis
Am. J. Roentgenol., June 1, 2007; 188(6): W584 - W584.
[Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
H. P. Forman
Back to the Beginning
Am. J. Roentgenol., February 1, 2007; 188(2): 295 - 296.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Roentgen Ray Society.